Zecuf Herbal Cough Lozenges (PINEAPPLE)

Indications

• Antioxidant support
• Enhancement of immune function
• Skin health improvement
• Digestive health support
• Metabolic syndrome management
• Hepatoprotective therapy

Dosage

Children: Refer to established herbal guidelines or consult a healthcare professional for appropriate dosing.

Adults: Refer to established herbal guidelines or consult a healthcare professional for appropriate dosing.

Mechanism of action

The active compounds in emblica, particularly emblicanin A and B, have been shown to exhibit antioxidant activity by scavenging free radicals and reducing oxidative stress. This action helps protect cells from damage, particularly in the liver and other organs. Additionally, emblica may modulate various biochemical pathways, including the enhancement of glutathione levels, which is critical for detoxification and cellular protection.

Pharmacodynamics

Emblica demonstrates a range of pharmacological effects, including anti-inflammatory, antimicrobial, and hepatoprotective actions. The fruit has been found to improve lipid profiles and glucose metabolism, making it potentially beneficial for metabolic syndrome and diabetes management. Furthermore, its immunomodulatory properties can enhance the immune response, contributing to overall health.

Pharmacokinetics

The pharmacokinetics of emblica are not extensively studied; however, its active compounds are believed to be rapidly absorbed in the gastrointestinal tract. The bioavailability and half-life of these compounds can be influenced by factors such as formulation and concurrent food intake. Metabolism primarily occurs in the liver, and excretion is likely via both renal and biliary pathways.

Adverse effects

• Gastrointestinal upset
• Diarrhea
• Nausea
• Vomiting
• Allergic reactions

Interactions

• May interact with anticoagulants, enhancing their effects
• Possible antagonism with certain chemotherapy agents

Precautions

• Use with caution in individuals with allergies to plants in the Euphorbiaceae family
• Monitor blood sugar levels in diabetic patients

Pregnancy

Limited human data available; use only if clearly needed and benefits outweigh risks.

Breast-feeding

Limited data available; consult a healthcare provider before use.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Powdered extract
• Capsules
• Tablets
• Liquid extract

Indications

• Gastrointestinal disorders (e.g., peptic ulcers, dyspepsia)
• Respiratory conditions (e.g., cough, bronchitis)
• Inflammatory conditions (e.g., arthritis, dermatitis)
• Viral infections (e.g., hepatitis, herpes simplex)

Dosage

Children: Refer to established clinical guidelines for appropriate dosing, as no specific dose is provided.

Adults: Refer to established clinical guidelines for appropriate dosing, as no specific dose is provided.

Mechanism of action

Glycyrrhizin, the active compound in glabra, inhibits the enzyme 11β-hydroxysteroid dehydrogenase type 2, leading to increased cortisol levels in tissues. This mechanism helps to reduce inflammation and modulate immune responses. Additionally, glabra exhibits antiviral activity by inhibiting the replication of certain viruses, possibly through interference with viral proteins and host cell interactions.

Pharmacodynamics

The pharmacodynamic effects of glabra are primarily attributed to glycyrrhizin and flavonoids present in the plant. Its anti-inflammatory effects are mediated through the inhibition of pro-inflammatory cytokines and pathways such as NF-κB. The compound also has expectorant properties, aiding in the relief of cough and respiratory distress by promoting mucus secretion and reducing irritation in the airways.

Pharmacokinetics

Glycyrrhizin is absorbed in the gastrointestinal tract, and its bioavailability can be influenced by the presence of other food components. Once absorbed, it undergoes hepatic metabolism, with its metabolites excreted primarily through urine. The half-life of glycyrrhizin can vary but is generally several hours, necessitating multiple doses for sustained therapeutic effects. Chronic use may lead to accumulation and potential side effects such as hypertension and hypokalemia due to its mineralocorticoid-like effects.

Pregnancy

The safety of glabra during pregnancy has not been established. It is advisable to avoid its use unless clearly needed.

Breast-feeding

There is limited information on the excretion of glabra in human milk. Caution is advised when administering to breastfeeding mothers.

Storage

Store at room temperature, away from moisture and direct light. Keep out of reach of children.

Indications

• Adrenal insufficiency
• Chronic inflammatory conditions

Mechanism of action

Glycyrrhizin, the primary active component of Glycyrrhiza, exerts its effects primarily through inhibition of the enzyme 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2). This inhibition prevents the conversion of active cortisol to inactive cortisone, leading to increased cortisol levels. Elevated cortisol mimics the effects of aldosterone, resulting in sodium retention, potassium excretion, and increased blood pressure. Additionally, licorice has anti-inflammatory and antiviral properties attributed to its ability to modulate various immune pathways and inhibit viral replication.

Pharmacodynamics

The pharmacodynamic effects of Glycyrrhiza include anti-inflammatory, antiviral, and immunomodulatory activities. Glycyrrhizin has been shown to reduce inflammation by inhibiting the production of pro-inflammatory cytokines and mediators. Its potential antiviral properties are particularly noted in viral infections such as hepatitis C and COVID-19, where it may inhibit viral replication. Furthermore, its ability to enhance the effects of corticosteroids can be beneficial in treating conditions associated with adrenal insufficiency or chronic inflammation.

Pharmacokinetics

Glycyrrhizin is absorbed from the gastrointestinal tract, with peak plasma concentrations occurring within 1-2 hours after oral administration. It undergoes extensive metabolism in the liver, primarily through conjugation processes, leading to the formation of glycyrrhetic acid as a major metabolite. The elimination half-life of glycyrrhizin is approximately 6-8 hours. Glycyrrhiza components are excreted in urine predominantly as conjugated forms. Long-term use can lead to accumulation and potential side effects due to its mineralocorticoid-like effects.

Contra-indications

• Hypertension
• Hypokalemia
• Severe kidney disease
• Pregnancy (due to hormonal effects)

Adverse effects

• Hypertension
• Hypokalemia
• Edema
• Headaches
• Fatigue
• Muscle weakness
• Cardiac arrhythmias (with excessive use)

Interactions

• May enhance the effects of corticosteroids
• May increase the risk of hypokalemia with diuretics
• May interact with anticoagulants, increasing the risk of bleeding
• May affect the metabolism of drugs metabolized by CYP3A4

Precautions

• Use with caution in patients with cardiovascular disease
• Monitor blood pressure and potassium levels during prolonged use
• Not recommended for long-term use without medical supervision

Pregnancy

Glycyrrhiza should be avoided during pregnancy as it may cause hormonal effects that could affect fetal development.

Breast-feeding

Consult a healthcare provider before use while breastfeeding, as safety is not well established.

Storage

Store in a cool, dry place, away from direct sunlight and moisture.

Formulations

• Dried root
• Extracts (liquid and powdered)
• Teas
• Capsules

Indications

• Topical analgesic for muscle and joint pain
• Cough suppressant in cough drops and lozenges
• Relief of minor throat irritation
• Cooling agent in various cosmetic and personal care products

Dosage

Children: Refer to BNF for Children for specific dosing guidelines, as doses may vary based on age and formulation.

Adults: For topical use, apply a thin layer to the affected area not more than 3 to 4 times daily. For cough drops, follow the product-specific instructions as per the formulation.

Mechanism of action

Menthol acts as an agonist for the transient receptor potential subtype M8 (TRPM8), a non-selective cation channel that is activated by cold temperatures. This activation leads to calcium influx in mast cells, inducing the release of histamine, which can trigger allergic responses such as urticaria, asthma, and rhinitis. Menthol's ability to induce histamine release via TRPM8 suggests potential therapeutic applications for TRPM8 antagonists in managing cold- and menthol-induced allergies.

Pharmacodynamics

Menthol produces a cooling effect by stimulating sensory neurons that convey cold sensations. It interacts with TRPM8 channels, leading to the activation of intracellular signaling pathways that can result in vasodilation and increased blood flow to the area of application. This cooling sensation can provide symptomatic relief in conditions characterized by pain or irritation.

Pharmacokinetics

Menthol is absorbed through the skin and mucous membranes, with systemic effects depending on the route of administration. Its bioavailability can vary, and it is metabolized primarily in the liver. The elimination half-life and excretion pathways have not been extensively characterized, but menthol is generally considered to have a rapid onset of action with effects lasting for a few hours.

Adverse effects

• Allergic reactions
• Urticaria
• Asthma
• Rhinitis
• Skin irritation

Precautions

• Use with caution in patients with known allergies to menthol or related compounds
• May exacerbate asthma in sensitive individuals

Pregnancy

There are no well-controlled studies of menthol in pregnant women. Menthol should be used during pregnancy only if clearly needed.

Breast-feeding

Menthol is excreted in breast milk. Caution should be exercised when administering to nursing mothers.

Storage

Store in a cool, dry place away from light. Keep out of reach of children.

Formulations

• Topical ointment
• Cream
• Liquid

Indications

• Wound healing
• Oral health (e.g., gingivitis, mouth ulcers)
• Anti-inflammatory conditions
• Gastrointestinal disorders (e.g., dyspepsia)
• Antimicrobial applications

Dosage

Children: Refer to established herbal guidelines as specific dosing information may vary based on preparation and condition being treated.

Adults: Refer to established herbal guidelines as specific dosing information may vary based on preparation and condition being treated.

Mechanism of action

The active compounds in officinale, such as resins and essential oils, exhibit their effects through various mechanisms, including the inhibition of pro-inflammatory cytokines and modulation of immune responses. These actions contribute to its analgesic and antimicrobial properties, making it beneficial in treating wounds and oral infections.

Pharmacodynamics

Myrrh has demonstrated a range of pharmacodynamic effects, including analgesia, anti-inflammatory activity, and antimicrobial action. The resin contains various terpenoids and phenolic compounds, which interact with biological pathways to exert these effects. Studies suggest that myrrh may inhibit the growth of certain bacteria and fungi, as well as reduce inflammation by blocking the synthesis of pro-inflammatory mediators.

Pharmacokinetics

The pharmacokinetics of myrrh are not well-defined due to variability in preparation and formulation. However, it is generally believed that the compounds are absorbed through the gastrointestinal tract when ingested, with some components potentially being metabolized in the liver. The onset of action may vary depending on the method of administration, with topical applications likely providing localized effects.

Pregnancy

Safety during pregnancy has not been established; consult a healthcare provider before use.

Breast-feeding

Consult a healthcare provider before using, as safety during breastfeeding is not well established.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Anxiety
• Sleep disorders
• Stress relief
• Mild depression
• Digestive issues

Dosage

Children: Dosage for paediatric patients should be determined by a qualified healthcare provider familiar

Adults: Dosage varies widely depending on the specific officinalis species and preparation. General guidance for herbal preparations should be followed, and consulting a healthcare professional is recommended.

Mechanism of action

The mechanism of action of officinalis species varies depending on the specific plant. For example, Melissa officinalis is thought to exert its effects primarily through modulation of GABA (gamma-aminobutyric acid) receptors, which are crucial for inhibitory neurotransmission in the brain. This interaction can lead to a calming effect, reducing anxiety and promoting sleep. Valeriana officinalis is believed to enhance GABAergic activity, potentially increasing GABA concentrations in the synaptic cleft, further contributing to its sedative properties.

Pharmacodynamics

Pharmacodynamics of officinalis species involve their effects on the central nervous system. The herbs are known to promote relaxation, reduce anxiety, and improve sleep quality. Their bioactive compounds, such as flavonoids and essential oils, are thought to influence neurotransmitter systems, particularly GABA, which plays a key role in anxiety regulation. Additionally, these plants may exhibit antioxidant properties, contributing to overall health benefits.

Pharmacokinetics

Pharmacokinetics of officinalis species can vary widely based on the specific plant and its preparation. Generally, the active components are absorbed in the gastrointestinal tract after ingestion. The onset of action can occur within 30 minutes to several hours, depending on the formulation. Metabolism occurs primarily in the liver, with elimination through urine. The half-life of the active compounds may vary, necessitating multiple doses for sustained effects.

Pregnancy

Consult healthcare provider before use. Limited data on safety in pregnancy.

Breast-feeding

Consult healthcare provider before use. Limited data on safety while breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Nausea and vomiting associated with motion sickness
• Nausea in pregnancy (morning sickness)
• Post-operative nausea and vomiting
• Osteoarthritis and other inflammatory joint conditions
• Dyspepsia and gastrointestinal discomfort

Dosage

Children: Refer to established guidelines and consult a healthcare professional for appropriate dosing based on formulation and indication.

Adults: Refer to established guidelines and consult a healthcare professional for appropriate dosing based on formulation and indication.

Mechanism of action

Ginger contains bioactive compounds, including gingerol and shogaol, which exhibit anti-inflammatory and antioxidant effects. The mechanism of action involves the inhibition of pro-inflammatory cytokines and enzymes, such as cyclooxygenase and lipoxygenase, leading to reduced inflammation. Ginger also enhances gastrointestinal motility and may exert a protective effect on the gastric mucosa.

Pharmacodynamics

The pharmacodynamic effects of ginger are primarily attributed to its active constituents, which modulate various physiological pathways. Gingerol and shogaol have been shown to influence the release of serotonin and other neurotransmitters, thereby alleviating nausea. Additionally, ginger's antioxidant properties help to mitigate oxidative stress in cells, contributing to its anti-inflammatory effects.

Pharmacokinetics

Ginger is rapidly absorbed in the gastrointestinal tract, with peak plasma concentrations of its active compounds occurring within 1-2 hours after ingestion. The bioavailability of gingerol and shogaol can be affected by the formulation and method of preparation (e.g., fresh, dried, or as an extract). The elimination half-life of these compounds is variable, with metabolism occurring primarily in the liver. They are excreted through urine and bile, and their effects can last for several hours.

Adverse effects

• Gastrointestinal discomfort
• Heartburn
• Nausea
• Diarrhea
• Skin irritation

Interactions

• Anticoagulants (e.g., warfarin)
• Antidiabetic medications
• Antihypertensive medications

Precautions

• Use with caution in patients with gallstones
• May affect blood sugar levels; monitor in diabetic patients
• May increase the risk of bleeding when used with anticoagulants

Pregnancy

Zingiber (ginger) is generally considered safe in food amounts during pregnancy. However, high doses should be avoided due to potential risks.

Breast-feeding

Zingiber is likely safe in food amounts while breastfeeding, but high doses should be avoided.

Storage

Store in a cool, dry place, away from direct sunlight.

Formulations

• Dried root
• Powder
• Capsules
• Tinctures
• Essential oil

Mechanism of action

Exposure to low temperatures often causes allergic responses or urticaria. Similarly, menthol, a common food additive is also known to cause urticaria, asthma, and rhinitis. However, despite the obvious clinical implications, the molecular mechanisms responsible for inducing allergic responses to low temperatures and menthol have not been determined. Because a non-selective cation channel, transient receptor potential subtype M8 (TRPM8) is activated by cold and menthol, we hypothesized that this channel mediates cold- and menthol-induced histamine release in mast cells. Here, we report that TRPM8 is expressed in the basophilic leukemia mast cell line, RBL-2H3, and that exposure to menthol or low temperatures induced Ca(2+) influx in RBL-2H3 cells, which was reversed by a TRPM8 blocker. Furthermore, menthol, a TRPM8 agonist, induced the dose-dependent release of histamine from RBL-2H3 cells. When TRPM8 transcripts were reduced by siRNA (small interfering RNA), menthol- and cold-induced Ca(2+) influx and histamine release were significantly reduced. In addition, subcutaneous injection of menthol evoked scratching, a typical histamine-induced response which was reversed by a TRPM8 blocker. Thus, our findings indicate that TRPM8 mediates the menthol- and cold-induced allergic responses of mast cells, and suggest that TRPM8 antagonists be viewed as potential treatments for cold- and menthol-induced allergies. /DL-Menthol/ Menthol's characteristic cooling sensation is due, in part, to the activation of sensory neurons generally termed transient receptor potential (TRP) channels, in particular transient receptor potential melastatin family member 8 (TRPM8) and transient receptor potential subfamily A, member 1 (TRPA1). Menthol acts upon TRPM8 receptors by rapidly increasing intracellular calcium and mobilizing calcium flux through the channels to induce cold response signals at the application site. Aside from its cold-inducing sensation capabilities, menthol exhibits cytotoxic effects in cancer cells, induces reduction in malignant cell growth, and engages in synergistic excitation of GABA receptors and sodium ion channels resulting in analgesia. /DL-Menthol/ In recent years, the transient receptor potential melastatin member 8 (TRPM8) channel has emerged as a promising prognostic marker and putative therapeutic target in prostate cancer. We have found that forced overexpression of TRPM8 in PC-3 cells can inhibit the cell proliferation and motility probably through the TRPM8 activation. In this study, we aimed to investigate whether activating the TRPM8 channel by its selective agonist menthol can inhibit the proliferation and motility of androgen-independent prostate cancer (AIPC) with remarkable expression of TRPM8. Menthol is a naturally occurring compound, which has been widely used in cosmetics and pharmaceutical products, and also as flavoring in food. DU145 cells are androgen-independent but have a remarkable expression of TRPM8. The demonstration of the existence of TRPM8 and the absence of TRPA1 in DU145 cells provided the foundation for the following experiments, because both TRPM8 and TRPA1 are molecular targets of menthol. The outcome of MTT assay indicated that menthol inhibited the cell growth (p < 0.01). Cell cycle distribution and scratch assay analysis revealed that menthol induced cell cycle arrest at the G(0)/G(1) phase (p < 0.01). Furthermore, menthol inhibited the migration of DU145 cells by downregulating the focal-adhesion kinase. So it suggests that the activation of the existing TRPM8 channels may serve as a potential and pragmatic treatment for those AIPC with remarkable expression of TRPM8, and menthol is a useful compound for future development as an anticancer agent. /DL-Menthol/